AviadoBio

Relentlessly chasing cures through groundbreaking science

London, United Kingdom · Founded 2021 · $168.5M raised

Headquarters
London
Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$168.5M
Last Round
$72.0M Series BApr 2025
Rounds
3

About

AviadoBio is a clinical-stage gene therapy company building on research from King's College London and UK Dementia Research Institute to develop potentially one-time treatments for neurodegenerative diseases. Uses engineered AAV vectors and proprietary vMiX RNA silencing. Lead program AVB-101 targets Frontotemporal Dementia caused by GRN mutations.

Summary

AviadoBio is a Biotech company based in London, United Kingdom, founded in 2021. It has raised $168.5M in total across 3 rounds, most recently a $72.0M Series B round in Apr 2025. Investors include New Enterprise Associates, Monograph Capital and Advent Life Sciences.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BApr 2025
$72.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AviadoBio on Indexed.vc
<a href="https://indexed.vc/companies/aviadobio"><img src="https://indexed.vc/api/badge/company/aviadobio" alt="AviadoBio on Indexed.vc" width="260" height="76" /></a>